OmniAb (OABI) Short-term Investments (2022 - 2026)
OmniAb (OABI) reported Short-term Investments of $20.0 million for Q1 2026, down 38.76% year-over-year from $32.7 million in Q1 2025, and down 29.74% quarter-over-quarter from $28.5 million in Q4 2025.
OmniAb (OABI) Short-term Investments (2022 - 2026) Analysis & Trends
OmniAb (OABI) has 5 years of Short-term Investments data on file, last reported at $20.0 million in Q1 2026.
- Short-term Investments for Q1 2026 came in at $20.0 million, down 38.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.0 million (down 38.76% YoY), and the FY2025 annual result was $28.5 million, down 10.48% from the prior year.
- Short-term Investments eased to $20.0 million in Q1 2026 per OABI's latest filing, from $28.5 million in the prior quarter.
- Over five years, Short-term Investments peaked at $90.7 million in Q1 2023 and troughed at $20.0 million in Q1 2026.
- A 5-year average of $47.1 million and a median of $34.6 million in 2024 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2023 and 2024: Short-term Investments gained 28.7% in 2023, then sank 57.36% in 2024.
- A 5-year view of Short-term Investments shows it stood at $54.9 million in 2022, then climbed by 28.7% to $70.6 million in 2023, then tumbled by 54.92% to $31.8 million in 2024, then fell by 10.48% to $28.5 million in 2025, then fell by 29.74% to $20.0 million in 2026.
- Business Quant data shows OABI's Short-term Investments at $20.0 million in Q1 2026, $28.5 million in Q4 2025, and $31.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.03 Mn |
| Dec 31, 2025 | 28.50 Mn |
| Sep 30, 2025 | 30.96 Mn |
| Jun 30, 2025 | 23.33 Mn |
| Mar 31, 2025 | 32.70 Mn |
| Dec 31, 2024 | 31.84 Mn |
| Sep 30, 2024 | 32.15 Mn |
| Jun 30, 2024 | 36.43 Mn |
| Mar 31, 2024 | 49.95 Mn |
| Dec 31, 2023 | 70.63 Mn |
| Sep 30, 2023 | 75.38 Mn |
| Jun 30, 2023 | 82.16 Mn |
| Mar 31, 2023 | 90.70 Mn |
| Dec 31, 2022 | 54.88 Mn |